missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ MFHAS1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA562347
This item is not returnable.
View return policy
Description
Immunogen sequence: PGLHYTVHIL CSKCLKRGSP NPHAFPGELL SQPRPEGVAE IICPKNGSER VNVALVYPPT PTVISPCSKK NVGEKHR Highest antigen sequence identity to the following orthologs: Mouse - 100%, Rat - 90%.
Identified in a human 8p amplicon, this gene is a potential oncogene whose expression is enhanced in some malignant fibrous histiocytomas (MFH). The primary structure of its product includes an ATP/GTP-binding site, three leucine zipper domains, and a leucine-rich tandem repeat, which are structural or functional elements for interactions among proteins related to the cell cycle, and which suggest that overexpression might be oncogenic with respect to MFH.
Specifications
| MFHAS1 | |
| Polyclonal | |
| Unconjugated | |
| MFHAS1 | |
| leucine rich repeat containing 65; LRRC65; malignant fibrous histiocytoma amplified sequence 1; malignant fibrous histiocytoma-amplified sequence 1; Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1; malignant fibrous histiocytoma-amplified sequences with leucine-rich tandem repeats 1; MASL1; MFH-amplified sequences with leucine-rich tandem repeats 1; MFHAS1 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 9258 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 0.05 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q9Y4C4 | |
| MFHAS1 | |
| Recombinant protein corresponding to Human MFHAS1. Recombinant protein control fragment (Product #RP-101337). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction